Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Egypt intl phr | Egitto | Salute | Prodotti farmaceutici | 7 Mrd EGP | 6,4x | 47,20 EGP | 1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Tenth of Ramadan | Egitto | Salute | Prodotti farmaceutici | 4,19 Mrd EGP | 18,5x | 12,42 | 2,78 EGP | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 42,8% Rialzo | Fai l’upgrade a Pro+ | |
Glaxo egypt | Egitto | Salute | Prodotti farmaceutici | 3,21 Mrd EGP | 24,1x | 0,11 | 37,88 EGP | 5,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Minapharm Pharmaceuticals | Egitto | Salute | Prodotti farmaceutici | 1,70 Mrd EGP | -6,3x | 0,04 | 155,69 EGP | 1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
October Pharma | Egitto | Salute | Prodotti farmaceutici | 1,52 Mrd EGP | 11,1x | 123,42 EGP | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Kahira Pharmaceuticals and Chemical Industries | Egitto | Salute | Prodotti farmaceutici | 1,23 Mrd EGP | 5,3x | 0,02 | 82,50 EGP | 9,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Alx. pharmaceu | Egitto | Salute | Prodotti farmaceutici | 1,17 Mrd EGP | 5,6x | 239,99 EGP | 4,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Macro Pharmaceutical | Egitto | Salute | Prodotti farmaceutici | 1,02 Mrd EGP | -2,5x | 0,01 | 1,84 EGP | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Nile pharmaceu | Egitto | Salute | Prodotti farmaceutici | 749,25 Mln EGP | 4,6x | 74 EGP | 5,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Arab Pharmaceuticals | Egitto | Salute | Prodotti farmaceutici | 570 Mln EGP | 6,4x | 0,26 | 95 EGP | 9,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sabaa Intl Pharma and Chemical Industries | Egitto | Salute | Prodotti farmaceutici | 226,50 Mln EGP | -34,8x | -4,33 | 0,91 EGP | 20% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Memphis Pharmaceuticals | Egitto | Salute | Prodotti farmaceutici | 212,62 Mln EGP | 1,1x | 37,79 EGP | 4,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |